Glucovance and Emphysema - a phase IV clinical study of FDA data

Summary:

Emphysema is reported as a side effect among people who take Glucovance (glyburide; metformin hydrochloride), especially for people who are male, 60+ old, also take Vicodin, and have Arthritis.

The phase IV clinical study analyzes which people have Emphysema when taking Glucovance. It is created by eHealthMe based on reports of 6,238 people who have side effects when taking Glucovance from the FDA, and is updated regularly.

What is Glucovance?

Glucovance has active ingredients of glyburide; metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 6,302 Glucovance users. Check the latest studies of Glucovance.

What is Emphysema?

Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs) is found to be associated with 1,078 drugs and 1,096 conditions by eHealthMe. Check the latest studies of Emphysema.

On Jul, 12, 2026

6,238 people reported to have side effects when taking Glucovance.
Among them, 16 people (0.26%) have Emphysema.

Among these 16 people:

What is the gender of people who have Emphysema when taking Glucovance? *

female: 25 %
male: 75 %

What is the age of people who have Emphysema when taking Glucovance? *

What are other drugs people take besides Glucovance? *

What are other side effects people have besides Emphysema? *

Pain: 12 people, 75.00%
Headache (pain in head): 12 people, 75.00%
Weight Decreased: 11 people, 68.75%
Confusional State: 11 people, 68.75%
Depression: 11 people, 68.75%
Fainting (loss of consciousness and postural tone): 11 people, 68.75%
Gallstones (stone formation by bile component): 11 people, 68.75%
Weakness: 11 people, 68.75%
Injury: 11 people, 68.75%
Asthma: 11 people, 68.75%

What are the existing conditions these people have? *

Stress And Anxiety: 2 people, 12.50%
Multiple Myeloma (cancer of the plasma cells): 2 people, 12.50%
Metastases To Prostate (cancer spreads to prostate): 2 people, 12.50%
High Blood Cholesterol: 2 people, 12.50%
Bone Disorder: 2 people, 12.50%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 12.50%
Osteoporosis (bones weak and more likely to break): 1 person, 6.25%
Malignant Respiratory Tract Neoplasm (cancer tumour of respiratory tract): 1 person, 6.25%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Glucovance and have Emphysema?

- Check whether Emphysema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glucovance:

Glucovance (6,302 reports)

Emphysema treatments and more:

Emphysema (29,685 reports)

How severe was Emphysema and when was it recovered:

Emphysema in Glucovance

Expand to all the drugs that have ingredients of glyburide; metformin hydrochloride:

Emphysema and drugs with ingredients of glyburide; metformin hydrochloride

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Glucovance:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Emphysema:

Emphysema (1,078 drugs)

Browse all the conditions that are associated with Emphysema:

Emphysema (1,096 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glyburide; metformin hydrochloride (the active ingredients of Glucovance) and Glucovance (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.